Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Humaidan

Showing results (221-230 of 262) with videos related to

Pageof 27
Sort By:
Fertility and Sterility|April 15, 2018
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic reviewCarlo Alviggi, Alessandro Conforti, Sandro C Esteves, et al.
Reproductive Biomedicine Online|May 1, 2021
The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patientsPeter Humaidan, Birgit Alsbjerg, Helle Olesen Elbaek, et al.
The Journal of Infectious Diseases|January 23, 2020
Corrigendum to: Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive OutcomeThor Haahr, Peter Humaidan, Helle Olesen Elbaek, et al.
Fertility and Sterility|October 10, 2019
Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic reviewSigne Taasti Andersen, Susanne Elisabeth Pors, Liv la Cour Poulsen, et al.
Reproductive Biology and Endocrinology : RB&E|June 22, 2021
Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trialsAlessandro Conforti, Sandro C Esteves, Peter Humaidan, et al.
The Journal of Infectious Diseases|January 1, 2019
Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive OutcomeThor Haahr, Peter Humaidan, Helle Olesen Elbaek, et al.
International Journal of Reproductive Biomedicine|April 21, 2018
Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center studyAbbas Aflatoonian, Mahnaz Mansoori-Torshizi, Maryam Farid Mojtahedi, et al.
Human Reproduction (Oxford, England)|March 30, 2018
Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth ratesAntonio La Marca, Christophe Blockeel, Ernesto Bosch, et al.
Human Reproduction (Oxford, England)|May 3, 2018
Corrigendum: Letter to the Editor: Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth ratesAntonio La Marca, Christophe Blockeel, Ernesto Bosch, et al.
Reproductive Biomedicine Online|February 17, 2024
APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular functionSandro C Esteves, Peter Humaidan, Filippo M Ubaldi, et al.
Pageof 27

Showing results (221-230 of 262) with videos related to

Sort By:
Pageof 27
Fertility and Sterility|April 15, 2018
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic reviewCarlo Alviggi, Alessandro Conforti, Sandro C Esteves, et al.
Reproductive Biomedicine Online|May 1, 2021
The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patientsPeter Humaidan, Birgit Alsbjerg, Helle Olesen Elbaek, et al.
The Journal of Infectious Diseases|January 23, 2020
Corrigendum to: Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive OutcomeThor Haahr, Peter Humaidan, Helle Olesen Elbaek, et al.
Fertility and Sterility|October 10, 2019
Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic reviewSigne Taasti Andersen, Susanne Elisabeth Pors, Liv la Cour Poulsen, et al.
Reproductive Biology and Endocrinology : RB&E|June 22, 2021
Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trialsAlessandro Conforti, Sandro C Esteves, Peter Humaidan, et al.
The Journal of Infectious Diseases|January 1, 2019
Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive OutcomeThor Haahr, Peter Humaidan, Helle Olesen Elbaek, et al.
International Journal of Reproductive Biomedicine|April 21, 2018
Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center studyAbbas Aflatoonian, Mahnaz Mansoori-Torshizi, Maryam Farid Mojtahedi, et al.
Human Reproduction (Oxford, England)|March 30, 2018
Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth ratesAntonio La Marca, Christophe Blockeel, Ernesto Bosch, et al.
Human Reproduction (Oxford, England)|May 3, 2018
Corrigendum: Letter to the Editor: Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth ratesAntonio La Marca, Christophe Blockeel, Ernesto Bosch, et al.
Reproductive Biomedicine Online|February 17, 2024
APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular functionSandro C Esteves, Peter Humaidan, Filippo M Ubaldi, et al.
Pageof 27